Heat Biologics' Grant - II Round

Heat Biologics raised a round of funding on March 11, 2010. Investors include National Institutes of Health.

Heat Biologics is a clinical-stage company focused on developing its off-the-shelf ImPACT therapeutic vaccines to combat a wide range of cancers and infectious diseases. ImPACT Therapy exploits the na…

Articles about Heat Biologics' Grant - II Round: